NCT03126435 2023-05-06
EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX
SynCore Biotechnology Co., Ltd.
Phase 3 Completed
Clinical Trials
4 trialsNCT01537536 2013-06-17
EndoTAG-1
Jules Bordet Institute
Phase 2 Completed
NCT00448305 2012-01-05
EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients
MediGene
Phase 2 Completed
NCT00377936 2008-11-14
EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas
MediGene
Phase 2 Completed